Clinical Trial Update: Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating sirolimus with PEG-asparaginase for acute lymphoblastic leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Pegaspargase (pegaspargase)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Emory University | Conditions: Acute Lymphoblastic Leukemia | Phase 1 | Status: WITHDRAWN